K2 HealthVentures Equity Trust LLC

Overview

• HeadquartersBoston, United States²
• Legal formLimited Liability Company²
• LEI549300NF71GG7D22WR32²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 7396109²

See how the biggest companies compare on our leaderboards

Corporate structure

K2 HealthVentures Equity Trust LLC sits at the top of its group. 9 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Timeline

1. Apr 29, 2019Founded K2 HealthVentures Equity Trust LLC is founded²

Stakes it holds

K2 HealthVentures Equity Trust LLC has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

• Neumora Therapeutics, Inc.SCHEDULE 13G/A Aug 11, 2025 to May 15, 2026³
• Alto Neuroscience, Inc.SCHEDULE 13G/A May 15, 2025 to Feb 17, 2026⁴
• TScan Therapeutics, Inc.SCHEDULE 13G/A Sep 30, 2022 to Feb 14, 2025⁵
• ASLAN Pharmaceuticals LtdSC 13G/A Mar 20, 2023 to Nov 14, 2024⁶
• Corbus PharmaceuticalsSC 13G/A Feb 14, 2024 to Nov 14, 2024⁷
• Elevation Oncology, Inc.SC 13G/A Sep 30, 2022 to Feb 14, 2024⁸
• Molecular Templates, Inc.SC 13G/A Jun 26, 2023 to Feb 14, 2024⁹
• Oncorus, Inc.SC 13G Nov 1, 2022¹⁰